Your session is about to expire
← Back to Search
Behavioural Intervention
ACN Stimulation for Obstructive Sleep Apnea (ACS Trial)
N/A
Recruiting
Led By David T. Kent, MD
Research Sponsored by Vanderbilt University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Scheduled for uni- or bilateral neck dissection (BND) for cervical lymphadenectomy of level IV and other indicated procedures for management of head and neck cancer.
Adult patient (≥18 years old).
Must not have
History of prior neck surgery with transection of the infrahyoid strap muscles as determined by clinical history.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up collected during a single operative procedure, taking about 15 minutes
Awards & highlights
No Placebo-Only Group
Summary
This trial will examine the anatomy of the ansa cervicalis and its effect on stimulating muscles to help improve sleep apnea.
Who is the study for?
This trial is for adults over 18 who are scheduled for neck surgery due to head and neck cancer. They must be able to give consent, without pre-existing neurological conditions or language barriers that prevent understanding the research, and no history of prior neck surgery that cut the infrahyoid strap muscles.
What is being tested?
The study tests nerve stimulation on a nerve called ansa cervicalis during surgery. It aims to see if stimulating this nerve can help open up the airway in patients with obstructive sleep apnea by activating certain neck muscles.
What are the potential side effects?
While specific side effects aren't listed, potential risks may include discomfort at the stimulation site, infection risk from electrode placement, or unexpected changes in muscle function.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am scheduled for surgery to remove lymph nodes in my neck due to head and neck cancer.
Select...
I am 18 years old or older.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I had neck surgery that involved cutting muscles below my voice box.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ collected during a single operative procedure, taking about 15 minutes
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~collected during a single operative procedure, taking about 15 minutes
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Primary Objective
Secondary study objectives
Secondary Objective
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Surgical ProcedureExperimental Treatment1 Intervention
Consented patients who meet eligibility will have a surgical procedure for management of head and neck cancer, with dissection and exposure of the relevant anatomic structures as part of regular clinical care.
Find a Location
Who is running the clinical trial?
Vanderbilt University Medical CenterLead Sponsor
908 Previous Clinical Trials
934,790 Total Patients Enrolled
David T. Kent, MDPrincipal InvestigatorVanderbilt University Medical Center
3 Previous Clinical Trials
220 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I had neck surgery that involved cutting muscles below my voice box.I am scheduled for surgery to remove lymph nodes in my neck due to head and neck cancer.I am 18 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: Surgical Procedure
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.